Clinical Trial

Coroflex® ISAR NEO PMCF Study

Study acronym: rEPIC07
Recruiting
View on ClinicalTrials.gov →
Summary
International, Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Coroflex® ISAR NEO coronary stent system to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Coroflex® ISAR NEO coronary stent system sirolimus eluting stent.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2023-01-16; most recent amendment 2026-04-30.
Status change: Not Yet Recruiting → Recruiting 2023-08-04
Trial Details
NCT Number NCT05698732
Lead Sponsor Fundación EPIC
Conditions Coronary Artery Disease (CAD), Ischemic Heart Disease
Enrollment 3,000 participants
Start Date 2023-08-04
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-14